• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型虚拟条码策略,用于在循环肿瘤 DNA 中进行准确的面板-wide 变异调用。

A novel virtual barcode strategy for accurate panel-wide variant calling in circulating tumor DNA.

机构信息

School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, China.

Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, China.

出版信息

BMC Bioinformatics. 2020 Apr 3;21(1):127. doi: 10.1186/s12859-020-3412-2.

DOI:10.1186/s12859-020-3412-2
PMID:32245364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7118954/
Abstract

BACKGROUND

Hybrid capture-based next-generation sequencing of DNA has been widely applied in the detection of circulating tumor DNA (ctDNA). Various methods have been proposed for ctDNA detection, but low-allelic-fraction (AF) variants are still a great challenge. In addition, no panel-wide calling algorithm is available, which hiders the full usage of ctDNA based 'liquid biopsy'. Thus, we developed the VBCALAVD (Virtual Barcode-based Calling Algorithm for Low Allelic Variant Detection) in silico to overcome these limitations.

RESULTS

Based on the understanding of the nature of ctDNA fragmentation, a novel platform-independent virtual barcode strategy was established to eliminate random sequencing errors by clustering sequencing reads into virtual families. Stereotypical mutant-family-level background artifacts were polished by constructing AF distributions. Three additional robust fine-tuning filters were obtained to eliminate stochastic mutant-family-level noises. The performance of our algorithm was validated using cell-free DNA reference standard samples (cfDNA RSDs) and normal healthy cfDNA samples (cfDNA controls). For the RSDs with AFs of 0.1, 0.2, 0.5, 1 and 5%, the mean F1 scores were 0.43 (0.250.56), 0.77, 0.92, 0.926 (0.861.0) and 0.89 (0.75~1.0), respectively, which indicates that the proposed approach significantly outperforms the published algorithms. Among controls, no false positives were detected. Meanwhile, characteristics of mutant-family-level noise and quantitative determinants of divergence between mutant-family-level noises from controls and RSDs were clearly depicted.

CONCLUSIONS

Due to its good performance in the detection of low-AF variants, our algorithm will greatly facilitate the noninvasive panel-wide detection of ctDNA in research and clinical settings. The whole pipeline is available at https://github.com/zhaodalv/VBCALAVD.

摘要

背景

基于杂交捕获的下一代测序技术已广泛应用于循环肿瘤 DNA(ctDNA)的检测。已经提出了各种用于 ctDNA 检测的方法,但低等位基因分数(AF)变体仍然是一个巨大的挑战。此外,没有面板范围的调用算法,这阻碍了基于 ctDNA 的“液体活检”的充分使用。因此,我们开发了 VBCALAVD(基于虚拟条码的低等位基因变体检测调用算法)来克服这些限制。

结果

基于对 ctDNA 碎片化本质的理解,建立了一种新的与平台无关的虚拟条码策略,通过将测序reads 聚类到虚拟家族中,消除随机测序错误。通过构建 AF 分布来打磨典型的突变家族级背景伪影。获得了另外三个强大的微调滤波器,以消除随机突变家族级噪声。使用无细胞 DNA 参考标准样本(cfDNA RSD)和正常健康 cfDNA 样本(cfDNA 对照)验证了我们算法的性能。对于 AF 分别为 0.1、0.2、0.5、1 和 5%的 RSD,平均 F1 分数分别为 0.43(0.250.56)、0.77、0.92、0.926(0.861.0)和 0.89(0.75~1.0),这表明该方法显著优于已发表的算法。在对照中,没有检测到假阳性。同时,清楚地描绘了突变家族级噪声的特征以及突变家族级噪声与 RSD 之间差异的定量决定因素。

结论

由于在检测低 AF 变体方面的良好性能,我们的算法将极大地促进研究和临床环境中 ctDNA 的非侵入性面板范围检测。整个流程在 https://github.com/zhaodalv/VBCALAVD 上可用。

相似文献

1
A novel virtual barcode strategy for accurate panel-wide variant calling in circulating tumor DNA.一种新型虚拟条码策略,用于在循环肿瘤 DNA 中进行准确的面板-wide 变异调用。
BMC Bioinformatics. 2020 Apr 3;21(1):127. doi: 10.1186/s12859-020-3412-2.
2
TNER: a novel background error suppression method for mutation detection in circulating tumor DNA.TNER:一种用于循环肿瘤 DNA 突变检测的新型背景误差抑制方法。
BMC Bioinformatics. 2018 Oct 20;19(1):387. doi: 10.1186/s12859-018-2428-3.
3
Structural variation and fusion detection using targeted sequencing data from circulating cell free DNA.利用循环游离 DNA 靶向测序数据进行结构变异和融合检测。
Nucleic Acids Res. 2019 Apr 23;47(7):e38. doi: 10.1093/nar/gkz067.
4
SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNA.SiNVICT:循环肿瘤 DNA 中单核苷酸变异和插入缺失的超灵敏检测。
Bioinformatics. 2017 Jan 1;33(1):26-34. doi: 10.1093/bioinformatics/btw536. Epub 2016 Aug 16.
5
Benchmarking UMI-aware and standard variant callers for low frequency ctDNA variant detection.基于 UMIs 的低频 ctDNA 变异检测与标准变异 caller 的基准测试
BMC Genomics. 2024 Sep 3;25(1):827. doi: 10.1186/s12864-024-10737-w.
6
Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing.肿瘤组织和循环肿瘤 DNA 中的异质性突变模式需要平行进行 NGS panel 检测。
Mol Cancer. 2018 Aug 28;17(1):131. doi: 10.1186/s12943-018-0875-0.
7
Analytical Validation of a Hybrid Capture-Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA.基于杂交捕获的下一代测序技术临床检测分析对游离循环肿瘤 DNA 进行基因组分析的验证
J Mol Diagn. 2018 Sep;20(5):686-702. doi: 10.1016/j.jmoldx.2018.05.004. Epub 2018 Jun 22.
8
A Pipeline for ctDNA Detection Following Primary Tumor Profiling Using a Cancer-Related Gene Sequencing Panel.一种使用癌症相关基因测序 panel 进行原发性肿瘤分析后 ctDNA 检测的流程。
Methods Mol Biol. 2019;1908:229-241. doi: 10.1007/978-1-4939-9004-7_16.
9
SinoDuplex: An Improved Duplex Sequencing Approach to Detect Low-frequency Variants in Plasma cfDNA Samples.SinoDuplex:一种改进的双端测序方法,用于检测血浆 cfDNA 样本中的低频变异。
Genomics Proteomics Bioinformatics. 2020 Feb;18(1):81-90. doi: 10.1016/j.gpb.2020.02.003. Epub 2020 May 16.
10
Aperture: alignment-free detection of structural variations and viral integrations in circulating tumor DNA.孔径:循环肿瘤 DNA 中结构变异和病毒整合的无比对检测。
Brief Bioinform. 2021 Nov 5;22(6). doi: 10.1093/bib/bbab290.

引用本文的文献

1
Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis.从血液中检测肿瘤突变及其在免疫治疗预后中的应用。
Nat Commun. 2021 Jul 7;12(1):4172. doi: 10.1038/s41467-021-24457-2.

本文引用的文献

1
Genome-wide cell-free DNA fragmentation in patients with cancer.癌症患者的全基因组游离 DNA 片段化。
Nature. 2019 Jun;570(7761):385-389. doi: 10.1038/s41586-019-1272-6. Epub 2019 May 29.
2
High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden.高产量 RNA 测序在 DNA 测序未检测到有丝分裂驱动改变且肿瘤突变负担低的肺腺癌中发现可靶向的激酶融合。
Clin Cancer Res. 2019 Aug 1;25(15):4712-4722. doi: 10.1158/1078-0432.CCR-19-0225. Epub 2019 Apr 26.
3
Competitive evolution of NSCLC tumor clones and the drug resistance mechanism of first-generation EGFR-TKIs in Chinese NSCLC patients.
中国非小细胞肺癌患者中NSCLC肿瘤克隆的竞争性进化及第一代EGFR-TKIs的耐药机制
Heliyon. 2018 Dec 19;4(12):e01031. doi: 10.1016/j.heliyon.2018.e01031. eCollection 2018 Dec.
4
Enhanced detection of circulating tumor DNA by fragment size analysis.通过片段大小分析增强循环肿瘤 DNA 的检测。
Sci Transl Med. 2018 Nov 7;10(466). doi: 10.1126/scitranslmed.aat4921.
5
Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients.检测胶质瘤患者脑脊液中的游离 DNA 片段化和拷贝数改变。
EMBO Mol Med. 2018 Dec;10(12). doi: 10.15252/emmm.201809323.
6
TNER: a novel background error suppression method for mutation detection in circulating tumor DNA.TNER:一种用于循环肿瘤 DNA 突变检测的新型背景误差抑制方法。
BMC Bioinformatics. 2018 Oct 20;19(1):387. doi: 10.1186/s12859-018-2428-3.
7
Standard operating procedure for somatic variant refinement of sequencing data with paired tumor and normal samples.使用配对的肿瘤和正常样本进行测序数据体细胞变异细化的标准操作程序。
Genet Med. 2019 Apr;21(4):972-981. doi: 10.1038/s41436-018-0278-z. Epub 2018 Oct 5.
8
Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab.基于血液的肿瘤突变负担可预测接受阿替利珠单抗治疗的非小细胞肺癌患者的临床获益。
Nat Med. 2018 Sep;24(9):1441-1448. doi: 10.1038/s41591-018-0134-3. Epub 2018 Aug 6.
9
ERASE-Seq: Leveraging replicate measurements to enhance ultralow frequency variant detection in NGS data.ERASE-Seq:利用重复测量提高 NGS 数据中超低频变异检测能力。
PLoS One. 2018 Apr 9;13(4):e0195272. doi: 10.1371/journal.pone.0195272. eCollection 2018.
10
A high-throughput assay for quantitative measurement of PCR errors.高通量测定聚合酶链反应错误的定量分析方法。
Sci Rep. 2017 Jun 2;7(1):2718. doi: 10.1038/s41598-017-02727-8.